<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sysmex Corporation — News on 6ix</title>
    <link>https://6ix.com/company/sysmex-corporation</link>
    <description>Latest news and press releases for Sysmex Corporation on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 05 Feb 2026 06:30:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/sysmex-corporation" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d63013beedb30cb6fc9326.webp</url>
      <title>Sysmex Corporation</title>
      <link>https://6ix.com/company/sysmex-corporation</link>
    </image>
    <item>
      <title>Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing</title>
      <link>https://6ix.com/company/sysmex-corporation/news/fujirebio-and-sysmex-begin-sales-collaboration-for-dementia-testing-1</link>
      <guid isPermaLink="true">https://6ix.com/company/sysmex-corporation/news/fujirebio-and-sysmex-begin-sales-collaboration-for-dementia-testing-1</guid>
      <pubDate>Thu, 05 Feb 2026 06:30:00 GMT</pubDate>
      <description>MINATO-KU, TOKYO, Japan &amp; KOBE, Japan, February 05, 2026--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President &amp; CEO: Goki Ishikawa; &quot;Fujirebio&quot;), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, &quot;Sysmex&quot;) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Busi</description>
    </item>
    <item>
      <title>Sysmex America Receives FDA Clearance for Automated Blood Coagulation Analyzer CN-Series CN-6000™</title>
      <link>https://6ix.com/company/sysmex-corporation/news/sysmex-america-receives-fda-clearance-for-automated-blood-coagulation-analyzer-cn-series-cn-6000tm</link>
      <guid isPermaLink="true">https://6ix.com/company/sysmex-corporation/news/sysmex-america-receives-fda-clearance-for-automated-blood-coagulation-analyzer-cn-series-cn-6000tm</guid>
      <pubDate>Wed, 25 Jun 2025 14:00:00 GMT</pubDate>
      <description>Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, has received FDA clearance for the CN-6000™ Automated Blood Coagulation Analyzer. This clearance includes the reagent products used in five commonly performed hemostasis tests:</description>
    </item>
    <item>
      <title>Sysmex Corporation Receives Health Canada License for the CN-3000™ &amp; CN-6000™ Automated Blood Coagulation Analyzers</title>
      <link>https://6ix.com/company/sysmex-corporation/news/sysmex-corporation-receives-health-canada-license-for-the-cn-3000tm-and-cn-6000tm-automated-blood-coagulation-analyzers</link>
      <guid isPermaLink="true">https://6ix.com/company/sysmex-corporation/news/sysmex-corporation-receives-health-canada-license-for-the-cn-3000tm-and-cn-6000tm-automated-blood-coagulation-analyzers</guid>
      <pubDate>Wed, 25 Jun 2025 14:00:00 GMT</pubDate>
      <description>Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, announces that Sysmex has received Health Canada license for the automated blood coagulation analyzers CN Series:</description>
    </item>
  </channel>
</rss>